Description of Research Expertise
Diabetes and obesity clinical trials.
Selected Publications
Authors: Emily Gleason BA, Lindsay Levine BA, Iris T. Lee, MD, Nathanael Koelper, MPH, Anastassia Amaro, MD, Anuja Dokras, MD, MHCI, PhD: Effect of Glucagon-Like Peptide 1 Receptor Agonist Pharmacotherapy on Weight Loss in Patients with and Without Polycystic Ovary Syndrome selected for oral presentation during the ASRM 2023 Scientific Congress : 2023.
R. Jones Jr, C. Maskart, J. Radway, A. Amaro, S. Cardillo: A Multimodal Curriculum to Improve Medical Student Gender-affirming Communication Skills, poster presentation. ENDO Society : 2023.
A. Rivadeneira Rodriguez, M. Walker, R. Gallop, A. Amaro: Single Center Retrospective Matched Cohort Study of glp1ra-Induced Weight Loss in Patients With Post-bariatric Weight Regain vs Non-surgical Controls, poster presentation. ENDO Society : 2023.
Amaro A, Skolnik NS, Sugimoto D.: Cardiometabolic risk factors efficacy of semaglutide in the STEP program. Postgrad Med. 134(sup1) : 18-27,2023.
Amaro A, Sugimoto D, Wharton S.: Efficacy and safety of semaglutide for weight management: evidence from the STEP program. Postgrad Med. 134(Sup1) : 5-17,2023.
Amaro A, Kaplan M, Massie DC.: Managed care considerations of weight management interventions for obesity. Am J Manag Care 28 (15 suppl): 307-318,2022.
Walker MP, Shenoy V, Metz DC, Stanley CA, Fraker D, Chandrasekhara V, Amaro A.: Case presentation of 8-year follow up of recurrent malignant duodenal Insulinoma and lymph node metastases and literature review of malignant Insulinoma management. BMC Endocr Disord 22 (1): 2022.
Massie DC, Amaro A, Kaplan M.: Patient well-being and the clinical and economic burdens associated with obesity in the United States Am J Manag Care 28 (15 suppl): 279-287,2022.
Chao AM, Tronieri JS, Amaro A, Wadden TA.: Clinical Insight on Semaglutide for Chronic Weight Management in Adults: Patient Selection and Special Considerations Drug Des Devel Ther 16 : 4449-4461,2022.
Chao AM, Tronieri JS, Amaro A, Wadden TA.: Semaglutide for the treatment of obesity Trends Cardiovasc Med 21 (00158-4): S1050-1738,2021.
Academic Contact Information
Penn Metabolic Medicine
3737 Market St
Philadelphia,
PA
19104
Patient appointments: 800-789-7366